Table 1 Clinical profiles of aspirin intolerance asthma and control subjects
From: Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population
Clinical profile | AIA | ATA |
|---|---|---|
Number of subjects (n) | 102 | 429 |
Age [year, mean (range)] | 42.76 (18.66-72.73)* | 47.30 (15.40-77.88) |
Sex (n, male/female) | 37/65 | 147/282 |
Smoker (current smoker/exsmoker) (%) | 21.36 (13.59/7.77)* | 30.07 (12.35/17.72) |
Height [cm, mean (range)] | 161.70 ± 9.91 | 160.42 ± 8.39 |
Weight (kg) | 61.64 ± 10.39 | 63.40 ± 10.97 |
Body mass index (kg/m2) | 23.56 ± 3.37* | 24.58 ± 3.39 |
% decline of FEV1 by aspirin provocation | 33.59 ± 13.42** | 3.54 ± 4.85 |
Blood eosinophil (%) | 6.65 ± 5.78 | 6.03 ± 5.92 |
FEV1 (% predicted) | 85.10 ± 16.41* | 91.66 ± 16.87 |
PC20 methacholine (mg/ml) | 4.26 ± 7.62* | 6.91 ± 8.90 |
Total IgE (IU/ml) | 415.74 ± 714.70 | 361.00 ± 607.56 |
Positive rate of skin test (%) | 48.04 | 57.81 |